Back to Search
INGER CHRISTENSEN, PHARMD
PHARMD
Pharmacist
NPI: 1255613600Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
4987729-1701(UT)
Research & Publications (20)
Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer.
PMID 19653096·Breast Cancer Res Treat·2010
8-other
Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma.
PMID 19528371·J Clin Oncol·2009
8-other
Changes in plasma TIMP-1 levels after resection for primary colorectal cancer.
PMID 19331135·Anticancer Res·2009
8-other
YKL-40 tissue expression and plasma levels in patients with ovarian cancer.
PMID 19134206·BMC Cancer·2009
8-other
Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
PMID 19261323·Gynecol Oncol·2009
8-other
Intact and cleaved forms of the urokinase receptor enhance discrimination of cancer from non-malignant conditions in patients presenting with symptoms related to colorectal cancer.
PMID 19672256·Br J Cancer·2009
8-other
Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas.
PMID 19438744·Histopathology·2009
8-other
Human glucagon receptor antagonists with thiazole cores. A novel series with superior pharmacokinetic properties.
PMID 19385613·J Med Chem·2009
7-preclinical
Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database.
PMID 19308749·Acta Obstet Gynecol Scand·2009
4-observational
Syncytin immunoreactivity in colorectal cancer: potential prognostic impact.
PMID 19327884·Cancer Lett·2009
8-other
Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.
PMID 18698413·PLoS One·2008
7-preclinical
Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer.
PMID 18840487·Adv Drug Deliv Rev·2008
6-review
Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer.
PMID 18794088·Clin Cancer Res·2008
8-other
Postoperative medical complications are the main cause of early death after emergency surgery for colonic cancer.
PMID 18563787·Br J Surg·2008
8-other
Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects.
PMID 18843001·Cancer Epidemiol Biomarkers Prev·2008
8-other
Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma.
PMID 18671804·Histopathology·2008
8-other
A comparative study of tissue inhibitor of metalloproteinases-1 levels in plasma and tumour tissue from patients with primary breast cancer and in plasma from patients with metastatic breast cancer.
PMID 18645261·Tumour Biol·2008
4-observational
Pre- and postoperative levels in serum of mannan-binding lectin associated serine protease-2 -a prognostic marker in colorectal cancer.
PMID 18638656·Hum Immunol·2008
8-other
Utilization of electromigration in civil and environmental engineering--processes, transport rates and matrix changes.
PMID 18569289·J Environ Sci Health A Tox Hazard Subst Environ Eng·2008
6-review
Novel glucagon receptor antagonists with improved selectivity over the glucose-dependent insulinotropic polypeptide receptor.
PMID 18707090·J Med Chem·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5554 S 1900 W
ROY, UT 84067 - Phone
- (801) 614-1263
Quick Facts
- NPI
- 1255613600
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile